IDEAYA Biosciences, Inc.

IDYA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001676725

SEC filings (opens in a new tab)

In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding IDEAYA Biosciences, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of IDYA: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	206	1	207	+2
Shares	92.0M	269.1K	93.9M	+2.19M (+2.4%)
Value	$2.36B	$6.92M	$1.54B	−$813.6M (−34.5%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to IDYA in Q1 2025
Institution	Shares	Value	% of portfolio
Rosalind Advisors, Inc.	700,000	$11.5M	5.59%
Algert Global LLC	306,708	$5.02M	0.12%
Nuveen, LLC	287,314	$4.71M	0.00%
Balyasny Asset Management LLC	217,857	$3.57M	0.01%
Cubist Systematic Strategies, LLC	190,421	$3.12M	0.04%
Point72 Asset Management, L.P.	140,125	$2.30M	0.01%
SummitTX Capital, L.P.	132,423	$2.17M	0.10%
StemPoint Capital LP	66,999	$1.10M	0.35%
Omers Administration Corp	31,000	$507.8K	0.00%
HRT Financial LP	21,220	$347.0K	0.00%
Dark Forest Capital Management LP	19,673	$322.2K	0.01%
SEI Investments Co	19,539	$320.1K	0.00%
Man Group plc	13,811	$226.2K	0.00%
American Century Companies Inc	11,908	$195.1K	0.00%
Virtus Investment Advisers, Inc.	6,368	$104.3K	0.03%
Coldstream Capital Management Inc	1,860	$30.5K	0.00%
Versant Capital Management, Inc	566	$9.27K	0.00%
Private Wealth Management Group, LLC	323	$5.29K	0.00%
Sierra Ocean, LLC	69	$1.13K	0.00%
Parkside Financial Bank & Trust	60	$982	0.00%
True Wealth Design, LLC	44	$721	0.00%
Park Place Capital Corp	40	$655	0.00%
Hughes Financial Services, LLC	26	$384	0.00%
Stephens Consulting, LLC	20	$328	0.00%
Boston Private Wealth LLC	19	$311	0.00%
CIBC Private Wealth Group, LLC	16	$232	0.00%
Skopos Labs, Inc.	4	$66	0.00%

Sold out (25)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of IDYA in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Boone Capital Management LLC	524,868	$13.5M
Marshall Wace, LLP	312,666	$8.04M
Superstring Capital Management LP	227,102	$5.84M
RTW Investments, LP	200,000	$5.14M
Neuberger Berman Group LLC	165,527	$4.25M
Neo Ivy Capital Management	130,806	$3.36M
Crestline Management, LP	95,428	$2.45M
Twinbeech Capital LP	87,802	$2.26M
Engineers Gate Manager LP	56,188	$1.44M
ExodusPoint Capital Management, LP	52,252	$1.34M
HighVista Strategies LLC	47,728	$1.23M
SG Americas Securities, LLC	18,486	$475.0K
Raymond James Financial Inc	16,769	$430.9K
EntryPoint Capital, LLC	14,670	$377.0K
AQR Capital Management LLC	13,763	$353.7K
Aigen Investment Management, LP	10,899	$280.1K
Virtus ETF Advisers LLC	2,758	$70.9K
JTC Employer Solutions Trusteee Ltd	1,547	$39.0K
R Squared Ltd	1,350	$34.7K
BFSG, LLC	400	$10.3K
Northwestern Mutual Wealth Management Co	44	$1.13K
Bessemer Group Inc	50	$1.00K
UMA Financial Services, Inc.	31	$797
Larson Financial Group LLC	29	$745
Riverview Trust Co	19	$488

Not filed for Q1 2025 yet (1)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IDYA in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	269,115	$6.92M